Yourgene
Yourgene Health Cystic Fibrosis Assay Receives IVDR Certification
The assay uses amplification-refractory mutation system (ARMS) technology and genetic analyzers to detect the 50 most common CF mutations in European ancestry populations.
In Brief This Week: Veracyte, Aspira Women's Health, Lucid Diagnostics, Mainz Biomed, More
News items for the week of Feb. 5, 2024.
Novacyt Preliminary Full-Year Non-COVID 2023 Revenues up 75 Percent
Pro forma revenues for the firm, which acquired Yourgene in September, declined 5 percent from 2022, excluding COVID-19-related sales.
In Brief This Week: Novacyt; Thermo Fisher Scientific; Devyser; Guardant Health; Angle; Gold Colloid
News items for the week of Sept. 4, 2023
In Brief This Week: Labcorp, Enzo; Revvity; Becton Dickinson; Yourgene, Illumina; More
News items for the week of July 24, 2023.
Apr 26, 2022
Yourgene Posts Twofold Rise in FY 2022 Revenues
Oct 26, 2021